183 related articles for article (PubMed ID: 31264373)
21. Orbital lymphoma: diagnostic approach and treatment outcome.
Eckardt AM; Lemound J; Rana M; Gellrich NC
World J Surg Oncol; 2013 Mar; 11():73. PubMed ID: 23506357
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin G4 (IgG4)-Positive Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma and Idiopathic Orbital Inflammation.
Sohn EJ; Ahn HB; Roh MS; Jung WJ; Ryu WY; Kwon YH
Ophthalmic Plast Reconstr Surg; 2018; 34(4):313-319. PubMed ID: 28749851
[TBL] [Abstract][Full Text] [Related]
23. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.
Masuda Y; Takeuchi K; Kodama T; Fujisaki T; Imaizumi Y; Otsuka E; Ozaki S; Hasebe S; Yakushijin Y
Int J Clin Oncol; 2019 Dec; 24(12):1620-1628. PubMed ID: 31172332
[TBL] [Abstract][Full Text] [Related]
24. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
25. Extraocular muscle involvement in MALT lymphomas.
Abalo-Lojo JM; Baleato-Gonzalez S; Abdulkader I; Gonzalez F
Orbit; 2011 Aug; 30(4):186-8. PubMed ID: 21780931
[TBL] [Abstract][Full Text] [Related]
26. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Lee WS; Suh C; Kim HJ
Int J Hematol; 2010 Oct; 92(3):510-7. PubMed ID: 20838958
[TBL] [Abstract][Full Text] [Related]
27. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
28. [Extranodal marginal zone lymphoma of the ocular adnexa].
Møller A; Specht L; Toft PB; Sjø LD
Ugeskr Laeger; 2008 Nov; 170(45):3660-3. PubMed ID: 18986616
[TBL] [Abstract][Full Text] [Related]
29. Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients.
Kiesewetter B; Lukas J; Kuchar A; Mayerhoefer ME; Streubel B; Lagler H; Müllauer L; Wöhrer S; Fischbach J; Raderer M
PLoS One; 2014; 9(7):e104004. PubMed ID: 25077481
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
[TBL] [Abstract][Full Text] [Related]
31. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.
Bailey EM; Ferry JA; Harris NL; Mihm MC; Jacobson JO; Duncan LM
Am J Surg Pathol; 1996 Aug; 20(8):1011-23. PubMed ID: 8712288
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma.
Nasser QJ; Pfeiffer ML; Romaguera J; Fowler N; Debnam JM; Samaniego F; El-Sawy T; McLaughlin P; Bakhoum MF; Esmaeli B
Leuk Lymphoma; 2014 May; 55(5):1013-7. PubMed ID: 23879202
[TBL] [Abstract][Full Text] [Related]
33. Orbital lymphoma masquerading as panuveitis.
Panda P; Forooghian F; Goodglick T; Chan CC; Nussenblatt R; Sen HN
Ocul Immunol Inflamm; 2010 Jun; 18(3):181-3. PubMed ID: 20482392
[TBL] [Abstract][Full Text] [Related]
34. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
36. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci.
Ruiz A; Reischl U; Swerdlow SH; Hartke M; Streubel B; Procop G; Tubbs RR; Cook JR
Am J Surg Pathol; 2007 May; 31(5):792-802. PubMed ID: 17460465
[TBL] [Abstract][Full Text] [Related]
37. Overview on the management of non-gastric MALT lymphomas.
Defrancesco I; Arcaini L
Best Pract Res Clin Haematol; 2018 Mar; 31(1):57-64. PubMed ID: 29452667
[TBL] [Abstract][Full Text] [Related]
38. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy.
Wenzel C; Fiebiger W; Dieckmann K; Formanek M; Chott A; Raderer M
Cancer; 2003 May; 97(9):2236-41. PubMed ID: 12712477
[TBL] [Abstract][Full Text] [Related]
39. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.
Charlotte F; Doghmi K; Cassoux N; Ye H; Du MQ; Kujas M; Lesot A; Mansour G; Lehoang P; Vignot N; Capron F; Leblond V
Virchows Arch; 2006 Apr; 448(4):506-16. PubMed ID: 16323006
[TBL] [Abstract][Full Text] [Related]
40. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]